“If my assumptions are correct (5% significance and 0.9 power), FDA is expecting that Leronimab will reduce the death rate in a factor of approximately 0.15 for approval.”

So, based on your assumption, the FDA may approve leronlimab if it can reduce the death rate by at least 15%?